Yes. 3 sessions/week × 45 minutes at 60–70% max HR.
Zone-2 endurance training (60–70% of max heart rate, conversational pace) is one of the most evidence-supported longevity interventions. It develops mitochondrial density, fat-oxidation capacity, and cardiovascular reserve. Three sessions of 45 minutes per week is the dose with the strongest evidence base.
For almost anyone training for healthspan, Zone 2 is a high-confidence, low-risk foundation. It costs nothing, stacks cleanly on top of strength work and a weekly VO2-max session, and the chain connecting mitochondrial fitness to all-cause mortality is among the best understood on this list. The main failure mode is going too hard: most people drift above Zone 2 and quietly convert an easy aerobic session into a mediocre tempo session.
Audited a tracked voice's Zone-2 podcast episode and reviewed San-Millán's mitochondrial-density literature, then cross-checked the dose and intensity claims against the broader endurance-training and cardiorespiratory-fitness cohort data.
Zone 2 requires patience — improvements are weekly, not daily. If you can't hold a full conversation, you're above Zone 2. A chest-strap heart-rate monitor is plenty; the exact zone boundary matters less than staying genuinely easy.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Not much. The mechanism, dose, and outcomes are settled. Personalization (HR zones derived from a lactate test rather than %max HR) is the next refinement.
Benefits hold across the populations where it's been tested.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
The effect size is large enough to matter clinically, not just statistically.
Most of the support comes from short or small studies.
Confounding and publication bias inflate the apparent benefit.
Most of the support comes from short or small studies.
Animal-model results don't translate to the human protocol being recommended.
Animal-model results don't translate to the human protocol being recommended.